thetaOwl

MRVL

Marvell Technology, Inc.Close $310.58EOD only
Max Pain
$262.50
Next expiry Jun 26, 2026
Expected Move
±$39.85
12.8% from close
Price Gap
-48.08
Distance to max pain
IV Rank
100
High premium
P/C OI
1.21
Slightly put-heavy
Consensus
7.0/10
Bullish tilt
Published snapshot: Jun 18, 2026 close
End-of-day snapshot

This page reflects MRVL options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.

Published Snapshot
Jun 18, 2026 close
MRVL AI Consensus Report
Analysis based on market close June 22, 2026

Historical consensus-supported lens with full content, report chain context, and metric rail.

Conviction
7.5

out of 10

7.5 not 9 because the pin risk and extreme IV (25-35% moves priced) temper conviction despite aligned bullish signals.

Where Perspectives Agree

All personas converge on bullish bias with support at $290, positive dealer gamma, and strong call flow driving near-term upside toward $307.

Where They Diverge

Directional expects continuation above $307, but earnings and theta highlight spot 6.2% above max pain ($290) as pin risk that could reverse gains.

Top Trade
via directional

Buy Sep 18 $290/$320 bull call spread for $15.00 debit – defined risk, captures upside while avoiding early pin.

Key Risk

Break below $290 support flips dealer gamma long and triggers stop-loss cascade, accelerating downside to $264.

How to Use These Reports
This ai consensus reflects the market close on June 22, 2026.
What the reports do

Each report translates the same market-close options snapshot into a specific lens such as directional bias, premium-selling posture, flow quality, or earnings setup.

How traders use them

Reports are most useful for narrowing the playbook, surfacing entry and risk context, and deciding which raw data page to inspect next.

What to remember

These are interpretation layers, not execution guarantees. Validate the setup against chain liquidity, expected move, and exposure before sizing risk.

If the report conviction and the raw data disagree, slow down and resolve the mismatch before sizing risk.